Ligand validation:7ETC

PYR: PYRUVIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7ETC_PYR_B_302	76%	11%	0.114	0.951	3.16	1.1	1	-	0	0	100%	1
7ETC_PYR_C_302	71%	12%	0.095	0.916	3.24	0.85	1	-	0	0	100%	1
7ETB_PYR_C_300	94%	21%	0.069	0.966	2.64	0.7	3	-	0	0	100%	1
7ETA_PYR_C_300	93%	8%	0.068	0.963	2.32	2.38	1	1	0	0	100%	1
7ETI_PYR_C_301	92%	15%	0.083	0.972	3.15	0.69	1	-	0	0	100%	1
7ETG_PYR_A_301	86%	15%	0.081	0.948	2.29	1.47	1	1	0	0	100%	1
7ETH_PYR_C_300	83%	19%	0.1	0.959	3.14	0.39	1	-	0	0	100%	1
4RV5_PYR_B_501	99%	17%	0.052	0.982	2.44	1.18	3	-	0	0	100%	1
2O9A_PYR_C_907	98%	2%	0.057	0.983	4.49	2.58	2	2	0	0	100%	1
5CM6_PYR_A_401	98%	11%	0.059	0.985	2.5	1.7	3	1	0	0	100%	1
3R75_PYR_B_702	98%	29%	0.062	0.987	1.5	1.32	1	1	0	0	100%	1
1WA3_PYR_A_1204	98%	21%	0.061	0.984	2.06	1.26	1	-	0	0	100%	0.8333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.